latest news on tirzepatide FDA says shortage of GLP-1 drug is over FDA approves weight-loss drug Zepbound

It helps slow down digestion, promotes a feeling of fullness after meals, reduces cravings, and improves how your body processes sugars and fats, leading to steady, sustainable fat loss

If you are experiencing persistent nausea, there are foods to avoid on semaglutide that can help minimize GI discomfort

In the SURMOUNT-1 trial, tirzepatide showed significant weight loss results in adults without diabetes over 72 weeks (15-21% body weight reduction, depending on dose), while orlistat typically produces more modest results (approximately 3-5% additional weight loss beyond placebo at 1 year)

Glucagon-like peptide-1 (GLP-1)-based therapeutics: current status and future opportunities beyond type 2 diabetes

Cholecystectomy increase

All were diagnosed with moderate to severe knee pain